Log in

NYSEAMERICAN:IBIO - Ibio Stock Price, Forecast & News

+0.05 (+16.95 %)
(As of 02/21/2020 02:18 AM ET)
Today's Range
Now: $0.35
50-Day Range N/A
52-Week Range
Now: $0.35
Volume15.35 million shs
Average Volume16.11 million shs
Market Capitalization$11.01 million
P/E RatioN/A
Dividend YieldN/A
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.

Industry, Sector and Symbol

Industry Biotechnology
Previous SymbolNASDAQ:IBIO



Sales & Book Value

Annual SalesN/A



Market Cap$11.01 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter.

Ibio (NYSEAMERICAN:IBIO) Frequently Asked Questions

What is Ibio's stock symbol?

Ibio trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IBIO."

When did Ibio's stock split? How did Ibio's stock split work?

Shares of Ibio reverse split before market open on Monday, June 11th 2018. The 1-10 reverse split was announced on Thursday, May 31st 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 8th 2018. An investor that had 100 shares of Ibio stock prior to the reverse split would have 10 shares after the split.

Has Ibio been receiving favorable news coverage?

News articles about IBIO stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ibio earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Ibio.

Who are some of Ibio's key competitors?

What other stocks do shareholders of Ibio own?

Who are Ibio's key executives?

Ibio's management team includes the folowing people:
  • Mr. Robert B. Kay, Exec. Chairman & CEO (Age 79)
  • Mr. Robert L. Erwin, Pres (Age 66)
  • Mr. James P. Mullaney CPA, CPA, Chief Financial Officer (Age 48)
  • Mr. Terence E. Ryan, Chief Scientific Officer (Age 64)
  • Dr. Renato Lobo, Chief Medical Officer

Who are Ibio's major shareholders?

Ibio's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.31%) and UBS Group AG (0.31%). View Institutional Ownership Trends for Ibio.

Which major investors are buying Ibio stock?

IBIO stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG and Virtu Financial LLC. View Insider Buying and Selling for Ibio.

How do I buy shares of Ibio?

Shares of IBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ibio's stock price today?

One share of IBIO stock can currently be purchased for approximately $0.35.

How big of a company is Ibio?

Ibio has a market capitalization of $11.01 million. Ibio employs 54 workers across the globe.View Additional Information About Ibio.

What is Ibio's official website?

The official website for Ibio is http://www.ibioinc.com/.

How can I contact Ibio?

Ibio's mailing address is 600 Madison Ave Ste 1601, NEW YORK, NY 10022-1737, United States. The biotechnology company can be reached via phone at +1-302-3550650.

MarketBeat Community Rating for Ibio (NYSEAMERICAN IBIO)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Ibio and other stocks. Vote "Outperform" if you believe IBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel